ArticlebioRxiv : the preprint server for biology2026
An Exponential Scale Mixture Model for Metatranscriptomics Data with Application to Inflammatory Bowel Disease.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Metatranscriptomic (MTX) sequencing enables profiling of gene expression across microbial communities, providing a framework for linking genetic potential with functional activity. However, standard pipelines report normalized abundances rather than raw counts, limiting the use of count-based RNA-seq methods, while Gaussian-based alternatives rely on transformations and assumptions that are often poorly suited to MTX data. We propose a new modeling framework for differential expression analysis of MTX data, built on a scale mixture of exponential distributions, that incorporates DNA abundance to adjust for genomic potential, accommodates subject-specific random effects, treats zeros as left-censored, and employs a mixture prior to handle extreme sparsity. Applied to the IBDMDB multi-omics cohort, differential expression results vary substantially across models, including among Gaussian approaches with different pseudocount choices. Our approach identifies a distinct subset of candidate genes not detected by existing Gaussian methods; these may provide useful leads toward a novel understanding of transcriptomic patterns associated with dysbiosis in inflammatory bowel disease. Estimated dysbiosis effect directions are consistent between our model and Gaussian-based approaches, while effect sizes from our model tend to be larger in absolute value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.